| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |